Publikation:

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Lade...
Vorschaubild

Dateien

Offensperger_2-12mdr75ce5vkv3.pdf
Offensperger_2-12mdr75ce5vkv3.pdfGröße: 576.86 KBDownloads: 46

Datum

2020

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Open Access Green
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Cell chemical biology. Cell Press. 2020, 27(12), pp. 1510-1520.e6. ISSN 2451-9456. eISSN 2451-9448. Available under: doi: 10.1016/j.chembiol.2020.08.017

Zusammenfassung

Genetic aberrations of the UBE3A gene encoding the E3 ubiquitin ligase E6AP underlie the development of Angelman syndrome (AS). Approximately 10% of AS individuals harbor UBE3A genes with point mutations, frequently resulting in the expression of full-length E6AP variants with defective E3 activity. Since E6AP exists in two states, an inactive and an active one, we hypothesized that distinct small molecules can stabilize the active state and that such molecules may rescue the E3 activity of AS-derived E6AP variants. Therefore, we established an assay that allows identifying modulators of E6AP in a high-throughput format. We identified several compounds that not only stimulate wild-type E6AP but also rescue the E3 activity of certain E6AP variants. Moreover, by chemical cross-linking coupled to mass spectrometry we provide evidence that the compounds stabilize an active conformation of E6AP. Thus, these compounds represent potential lead structures for the design of drugs for AS treatment.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Angelman syndrome; E6AP; UBE3A ; ubiquitin ligase; fluorescence polarization; high-throughput screen; small-molecule activator; cross-linking coupled to mass spectrometry; XL-MS

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690OFFENSPERGER, Fabian, Franziska MÜLLER, Jasmin JANSEN, Daniel HAMMLER, Kathrin H. GÖTZ, Andreas MARX, Carissa L. SIROIS, Stormy J. CHAMBERLAIN, Florian STENGEL, Martin SCHEFFNER, 2020. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants. In: Cell chemical biology. Cell Press. 2020, 27(12), pp. 1510-1520.e6. ISSN 2451-9456. eISSN 2451-9448. Available under: doi: 10.1016/j.chembiol.2020.08.017
BibTex
@article{Offensperger2020-12-17Ident-51153,
  year={2020},
  doi={10.1016/j.chembiol.2020.08.017},
  title={Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants},
  number={12},
  volume={27},
  issn={2451-9456},
  journal={Cell chemical biology},
  pages={1510--1520.e6},
  author={Offensperger, Fabian and Müller, Franziska and Jansen, Jasmin and Hammler, Daniel and Götz, Kathrin H. and Marx, Andreas and Sirois, Carissa L. and Chamberlain, Stormy J. and Stengel, Florian and Scheffner, Martin}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/51153">
    <dc:contributor>Jansen, Jasmin</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/51153"/>
    <dc:language>eng</dc:language>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:issued>2020-12-17</dcterms:issued>
    <dc:contributor>Müller, Franziska</dc:contributor>
    <dc:contributor>Marx, Andreas</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51153/1/Offensperger_2-12mdr75ce5vkv3.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Offensperger, Fabian</dc:creator>
    <dc:contributor>Stengel, Florian</dc:contributor>
    <dcterms:title>Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Sirois, Carissa L.</dc:creator>
    <dcterms:abstract xml:lang="eng">Genetic aberrations of the UBE3A gene encoding the E3 ubiquitin ligase E6AP underlie the development of Angelman syndrome (AS). Approximately 10% of AS individuals harbor UBE3A genes with point mutations, frequently resulting in the expression of full-length E6AP variants with defective E3 activity. Since E6AP exists in two states, an inactive and an active one, we hypothesized that distinct small molecules can stabilize the active state and that such molecules may rescue the E3 activity of AS-derived E6AP variants. Therefore, we established an assay that allows identifying modulators of E6AP in a high-throughput format. We identified several compounds that not only stimulate wild-type E6AP but also rescue the E3 activity of certain E6AP variants. Moreover, by chemical cross-linking coupled to mass spectrometry we provide evidence that the compounds stabilize an active conformation of E6AP. Thus, these compounds represent potential lead structures for the design of drugs for AS treatment.</dcterms:abstract>
    <dc:creator>Chamberlain, Stormy J.</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51153/1/Offensperger_2-12mdr75ce5vkv3.pdf"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Hammler, Daniel</dc:contributor>
    <dc:creator>Jansen, Jasmin</dc:creator>
    <dc:contributor>Sirois, Carissa L.</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-01T09:51:11Z</dc:date>
    <dc:contributor>Scheffner, Martin</dc:contributor>
    <dc:contributor>Offensperger, Fabian</dc:contributor>
    <dc:contributor>Götz, Kathrin H.</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:creator>Scheffner, Martin</dc:creator>
    <dc:creator>Götz, Kathrin H.</dc:creator>
    <dc:creator>Marx, Andreas</dc:creator>
    <dc:creator>Stengel, Florian</dc:creator>
    <dc:contributor>Chamberlain, Stormy J.</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-01T09:51:11Z</dcterms:available>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:creator>Müller, Franziska</dc:creator>
    <dc:creator>Hammler, Daniel</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen